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Abstract
Background: Recently changed guidelines for child health surveillance in the United Kingdom (U.K.)
suggest targeted checks only, instead of the previously conducted routine or universal screening at 2 years
and 3.5 years. There are concerns that these changes could lead to a delay in the detection of children
with autism and other pervasive developmental disorders (PDD). Recent U.K. studies have suggested that
the prevalence of PDD is much higher than previously estimated. This study establishes to which extent
the routine checks contributed to the early detection and assessment of cases of PDD. Simultaneously we
have evaluated the process involved and estimate the prevalence of PDD in our district.
Methods: Retrospective study design utilising community medical files. Headteachers of schools (n = 75)
within Maidstone district (Kent) were asked to report all children with an established diagnosis of autism
or PDD attending year 4 (born '91 and '92 / n = 2536) in October 2000 based on educational records.
Results: 59 schools (78.7%) took part in the study. A total of 33 children were reported. 21 fulfilled the
inclusion criteria (12 falsely reported). The prevalences were (per 10,000): PDD 82.8 (male to female ratio
6:1), childhood autism 23.7, Asperger's syndrome 11.8 and autistic spectrum disorder 47.3. Co-existing
medical conditions were noted in 14.3%; 52.4% were attending mainstream schools. In 63.2% of cases
concerns – mainly in the area of speech and language development (SLD) – had been documented at the
2 year check. At the 3.5 year check concerns were noted in 94.1% – the main area was again SLD (76.5%),
although behavioural abnormalities were becoming more frequent (47.1%). A total of 13 children (68.4%)
were referred for further assessment as a direct result of the checks.
Conclusions: The prevalences for different types of PDD were similar to figures published recently, but
much higher than reported a few years ago. Analysis of our data suggests that routine surveillance is a
valuable contributing factor for the early detection of PDD and thereby facilitates early intervention. Thus,
if routine surveillance ceases, then an alternative method of early detection should be put in place.
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Background
Autism and other pervasive developmental disorders
(PDD) continue to be an area of major public concern,
especially in the light of recent debates about possible
links between the MMR vaccine and these conditions. An
increasing number of publications have since demon-
strated that there is no association between the vaccine
and the development of autism or PDD [1-3].
Since 1966, when the first epidemiological survey of autis-
tic conditions in England was published by Lotter [4], sev-
eral studies have been performed worldwide. However,
there has been little epidemiological data available in the
last decade regarding the United Kingdom until Chakra-
barti and Fombonne [5] published a survey conducted
amongst pre-school children. The authors found that the
rates of PDD were considerably higher in their population
than in previous reports.
Routine Child Health Surveillance – which includes a 2-
year and a 3.5-year check – used to be an important
screening tool for the paediatric population in the United
Kingdom. The assessments, which were carried out by a
health professional, consisted of testing and enquiring
about vision, hearing, motor development, speech devel-
opment and behavioural aspects. The latter two areas are
particularly of relevance in the detection of PDD.
In recent years many Community Child Health Depart-
ments have ceased to carry out routine 2-year and 3.5-year
developmental surveillance checks. Instead of the univer-
sal screening of the entire population, targeted or selective
screening has been introduced in many areas. Some
health care trusts have been forced to adopt these policies
earlier because of financial constraints and shortage of
staff.
There have been concerns about the possibility that this
change could consequently lead to a later detection of
cases of PDD, especially at the "milder end" of autistic
spectrum disorders. Early detection of these children and
intervention is essential, since this can lead to considera-
ble improvement in outcome as previously demonstrated
by various authors [6-8].
In this study we tried to assess to what extent the 2- and
3.5-year check (in a period when these checks were rou-
tinely carried out) contributed to the early detection of
PDD. Simultaneously we intended to estimate the preva-
lence of the different types of PDD in our area and evalu-
ate the process which has led to the diagnosis of these
cases. Another aim was to obtain more detailed informa-
tion about these patients, such as gender distribution,
coexisting medical conditions, therapeutic interventions
and schooling.
Methods
This retrospective study was conducted on a paediatric
population in Maidstone district (Kent, U.K.). The area
comprises of a mixture of urban, rural and semi-industrial
areas. The total population living in this area was 220.239
in June 2000 (49.0 % male, 51.0% female). The majority
of the population was of British Caucasian origin, with a
relatively small proportion of immigrants and foreigners
of 1.4 %, predominately of Indian (n = 763) and Afro-
Carribean (n = 592) origin. The social class distribution
based on occupation was as follows: I 4.8%, II 32.5%, III
manual 19.7%, III non-manual 24.5%, IV 13.2% and V
5.4%.
We included all school children who were attending year
4 in the 75 schools (born in 1991–1992, aged 8–9 years)
within in the catchment area of the Maidstone district on
the 1st of October 2000. Since many features of PDD
become more pronounced with increasing age we decided
to concentrate on this particular age group of children. By
that age the majority of children with significant autistic
difficulties are likely to have presented. The total number
of children included in the survey was 2,536.
Headteachers and Special Educational Needs Coordina-
tors of all primary schools were informed about this study
by written correspondence. They were asked to provide a
list – based on their educational records – of all children
attending their school who were believed to have a defi-
nite or established diagnosis of any of the following disor-
ders: autism, autistic spectrum disorder, Asperger's
syndrome, semantic pragmatic language disorder, perva-
sive developmental disorder or atypical autism.
The next step was to obtain the community medical files
of all children reported by the schools. These files contain
information about child health surveillance assessments,
medical problems and treatment, developmental assess-
ments, therapy reports and the statements for special edu-
cational needs. The files were systematically reviewed by
two of the authors (V.N. and M.T.) to obtain information
about the diagnosis, age at diagnosis and which type of
professional had made the diagnosis. The diagnostic
validity was checked by matching symptoms documented
in the notes against ICD-10 criteria. Each of the two
authors reviewed the notes independently and assigned
the child to one of the 3 categories outlined below.
We focused on the pre-school health surveillance checks
performed at 2 years and 3.5 years to assess if and which
concerns had been documented and whether they had
been acted upon. The initial referral was considered to be
the direct result of a routine check if the referral was made
within 4 weeks following the check.BMC Pediatrics 2004, 4 http://www.biomedcentral.com/1471-2431/4/4
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Further details which we included were therapeutic inter-
ventions, additional assistance at school, whether the
child was statemented for special educational needs and
whether the child was attending a mainstream-school or a
specialised school.
For the purpose of this study we have chosen to divide our
patients with pervasive developmental disorder (PDD)
into three groups: childhood autism, Asperger's syndrome
and autistic spectrum disorder. In this paper we are using
the term childhood autism according to ICD-10 criteria to
describe children who have been referred to as "infantile
autism", "autistic disorder" or "autistic syndrome" by
other authors. Asperger's syndrome was defined by using
ICD-10 criteria and the widely used criteria published by
Gillberg and Gillberg [9]. The term autistic spectrum dis-
order is used to describe a collection of all other pervasive
developmental disorders not fulfilling the criteria of the
other two categories, including atypical autism and
semantic pragmatic language disorder (ICD-10 categories
F 84.1, F 84.8 and F 84.9).
Results
Out of 75 schools within the Maidstone district 59
(78.7%) responded. The other 16 schools (21.3%) did
not participate in the study, despite repeated correspond-
ence and assurance that they would not be breaching con-
fidentiality as this was a survey of known medical details
and no family would be contacted. All schools for chil-
dren with special needs including the unit for the hearing
impaired took part in the study. The total number of chil-
dren attending year 4 within our area at the time when the
study was undertaken was 2,536.
The total number of children reported was 33. The com-
munity medical files of all these children were obtained
and independently reviewed by the authors as described
above. The concordance between reviewers regarding
assignment of cases to a particular diagnostic category or
exclusion from the study (i.e. falsely reported case) was
100%.
We found that 21 of these children had been diagnosed
with a type of pervasive developmental disorder, but 12
children did not have a diagnosis of PDD and thus had
been reported falsely. The most common diagnosis in the
latter group were speech and language delay, ADHD
(attention deficit hyperactivity disorder) and moderate
learning difficulties. Some children had more than one
diagnosis (see table 1). The false reports came from 5 dif-
ferent schools.
Out of the 21 children (total prevalence of PDD 82.8 per
10.000) who fitted the inclusion criteria 6 had a diagnosis
of childhood autism (prevalence 23.7 per 10.000), 3 had
Asperger's syndrome (prevalence 11.8 per 10.000) and 12
had autistic spectrum disorder (prevalence 47.3 per
10.000). The male:female ratio for the whole group was
6:1. All children diagnosed with childhood autism were
male.
The mean age at diagnosis for the whole group was 4.99
years (range 2.75 – 9.42 years, median 4.42 years). The
mean age at diagnosis varied considerably between the
subgroups (see table 2). The subgroup of children with
childhood autism had the lowest mean age at diagnosis
(mean 3.13 years, range 2.75 – 3.50). All children in this
subgroup had symptoms before 36 months of age.
In 14 patients (66.7%) the diagnosis was established at
pre-school age, 7 (33.3%) were diagnosed after entering
school (>5.0 years of age).
The majority of children (n = 14 / 66.7 %) were assessed
and diagnosed by Consultant Community Paediatricians.
In three cases the diagnosis was made by experienced
Community Child Health doctors. One child with
Asperger's syndrome was diagnosed by a Consultant Psy-
chiatrist and another child with atypical autism by a
multidisciplinary team at a tertiary referral centre. Two
children with semantic pragmatic language disorder were
diagnosed by Speech and Language Therapists.
All 14 children diagnosed by the Consultant Community
Paediatricians were also regularly followed up by them or
the school health service. One patient with Asperger's syn-
drome was followed up by the Child and Adolescent Men-
tal Health Service. All 21 children who were included into
the study had previously been assessed and treated by the
Speech and Language Therapy team, most of them contin-
ued to be seen by that department.
Coexisting conditions were documented in 10 children
(47.6%). The most common condition was ADHD,
present in 5 children (23.8%). One patient (4.8%) was
diagnosed with dyspraxia and one with dyslexia. Two
Table 1: Diagnosis in the group of falsely reported children
Diagnosis / condition Number of children
ADHD 3
cerebral palsy 2
Dyspraxia 2
Epilepsy 1
learning difficulties 3
sensorineural hearing loss 1
speech and language delay 4
Table 1 shows the spectrum of diagnosis in children not fulfilling 
inclusion criteria (n = 12), who were falsely reported by the 
participating schools. Four children had more than one diagnosis.BMC Pediatrics 2004, 4 http://www.biomedcentral.com/1471-2431/4/4
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patients (9.5%) were suffering from epilepsy and one had
hydrocephalus.
Eleven children (52.4%) were attending mainstream
schools, ten (47.6%) were attending special schools. All
but one child diagnosed with childhood autism were
attending special schools. A total of 19 children (90.5 %)
were formally statemented for special educational needs
and received additional support at school. Two children
(9.5%) – one child with Asperger's syndrome and one
with semantic pragmatic language disorder – had not
been statemented, but received additional support in the
school setting.
The 2-year check had been carried out in all 19 children
born in our area as part of the routine pre-school health
surveillance. Two patients had moved into the area after
two years of age. In both cases information on health-
checks was not available.
In a total of 12 (63.2%) children abnormalities or con-
cerns were documented at the 2-year-check. The most
common area of concern was speech and language devel-
opment (see table 3). In all children with childhood
autism (n = 6) abnormalities were noted at this stage. In 7
(36.8 %) patients there were no concerns raised at this
point.
The 3.5-year-check had been performed on 17 children.
Concerns were documented in 16 cases (94.1 %). The
main area of concern continued to be speech and lan-
guage development (13 cases / 76.5 %), followed by con-
cerns about behaviour (8 cases / 47.1 %). Only in one case
– a child later diagnosed with Asperger's syndrome – there
had been no concerns at that point (see table 4).
The mean age at the initial referral was 3.47 years (range
1.67 – 6.0 years, median 3.42, mode 3.5 years). The most
common area of concern raised in the initial referral letter
was speech and language development (18 cases / 85.7%)
followed by concerns about social interaction (10 cases /
47.6%). Unusual behaviour was mentioned in 9 cases
(42.9%) at referral. This included obsessive, ritualistic,
stereotypic behaviour, fixation on certain objects, resist-
ance to change in routines and echolalia. Other concerns
at referral were aggressive behaviour and short attention
span (see table 5).
The next stage of the study was to assess the number of
referrals which were made as a direct result of the routine
checks. A total of 13 children (68.4%) were referred for
further specialist assessment as an outcome of the checks
– 5 children (26.3%) and 8 children (42.1%) following
the 2-year and 3.5-year checks respectively. In 6 cases
(31.6%) referrals were made unrelated to the routine
checks. One child was referred before the 2-year check, 2
children were referred between the 2-year and 3.5-year
checks and 3 children were referred sometime after the
3.5-year check.
Discussion
In this study we found the prevalence of PDD was at least
82.8 per 10.000 children which is even higher than previ-
ously reported. We consider this to be the minimum prev-
alence rather than the actual prevalence as a quarter of the
schools did not respond. This relatively high prevalence
may be accounted for by the fact that we concentrated on
school-age children rather than on pre-school children
like Chakrabarti and Fombonne [5], who reported a prev-
alence of 62.6 per 10.000. Fourteen children in our study
population had been diagnosed before school entry,
which would equal a prevalence of 55.2 per 10.000 at that
point in time. However, it is noteworthy that the National
Autistic Society (NAS) recently estimated the total preva-
lence of PDD to be 91 per 10,000 [10].
Observations of other authors support the impression
that the incidence – and thereby also prevalence – of PDD
has increased over the last decade [11-14]. Powell et al.
[15] found that the incidence of autistic spectrum disor-
ders in their population appeared to have increased by
55% per year over a five year period (1991–1996). The
authors of this paper came to the conclusion that clini-
cians were becoming increasingly able and willing to
make this diagnosis in pre-school children, rather than
the data reflecting a "true" rise in number of cases. This
theory has since been supported by a number of recent
publications [14-16]. Interestingly, a recent epidemiolog-
Table 2: Mean age at diagnosis
Diagnosis Number of patients Mean age at diagnosis Range (years)
Childhood autism 6 3.13 2.75 – 3.50
Asperger's syndrome 3 7.22 5.75 – 9.25
Autistic spectrum disorder 12 5.37 3.33 – 9.42
Table 2 shows the mean age at diagnosis and the range of age at which the diagnosis was made according to diagnostic subgroups.BMC Pediatrics 2004, 4 http://www.biomedcentral.com/1471-2431/4/4
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ical study in the U.K. has suggested that the incidence of
PDD appears to have stabilised in the last few years [17].
In our study the prevalence of 23.7 per 10.000 for child-
hood autism was also higher than previously reported by
other authors [5,17,18]. However, two recently published
studies from groups in the United States have reported
similar figures. Croen et al. reported a prevalence of 14.9
per 10.000 in Californian children [14], while the preva-
lence reported by Bertrand et al. in children from New Jer-
sey was 40.0 per 10.000 [19].
Our prevalence for Asperger's syndrome (11.8 per 10.000)
was lower than reported by Ehlers and Gillberg [20] (36
per 10.000), but higher than recently published by
Chakrabati and Fombonne [5]. Again the explanation for
the higher incidence of Asperger's syndrome in compari-
son to the latter group is likely to be due to the difference
in age of our populations. Two of our three patients in this
subgroup were only diagnosed after school entry.
The male preponderance we found in our study popula-
tion of children with PDD was similar to observations
published by other authors [5,17,21,22].
It was reassuring to find that all children in our study were
assessed and treated by the Speech and Language Therapy
team and received additional support at school, with the
majority (90.5%) having been statemented for special
educational needs. A tendency for improvements regard-
ing statementing and special provisions at school for chil-
dren with PDD has previously been reported by Smith et
al. [23].
For a considerable proportion of children with PDD
(36.8%), no areas of concern were noted at the 2-year
child health surveillance check. In contrast to this in
nearly all cases of PDD (94.1%) abnormalities had been
noted at the 3.5-year check. Abnormal development had
been documented in all cases of childhood autism at the
2-year check, but a significant amount of "milder" cases of
PDD – including all 3 patients later diagnosed with
Asperger's syndrome – had not been detected at that stage.
We found that at the 3.5-year check concerns about
speech and language development had been raised in
about 3/4 of the PDD cases (vs. only 57.9% at 2-year
check) and that behavioural concerns were noted far more
frequently (47.1% vs. 5.3%). These results suggest that the
3.5-year check – and to a lesser extent the 2-year check –
is a valuable contributing factor in the early detection of
PDD.
Another important finding was that 68.4% of the children
with PDD were referred for further assessment as a direct
result of the routine child health surveillance checks. This
illustrates that abnormalities were not only noted and
documented at the checks, but that action was taken in a
large proportion of children to address these issues
appropriately.
Recently the Joint Working Party on Child Health Surveil-
lance (U.K.) has published a new edition of "Health For
Table 3: Areas of concern documented at the 2 year check
Areas of concern at 2 yrs Number of cases
Speech and language development 11 (57.9%)
Hearing 1 (5.3%)
Motor development 1 (5.3%)
Behaviour 1 (5.3%)
None 7 (36.8%)
Table 3 shows the areas of concerns which were documented in the 
child health surveillance check at 2 years of age in children with PDD 
(n = 19). In two children there were two areas of concern noted. 
There was no data on 2 children who had moved into the area at a 
later point in life.
Table 4: Areas of concern documented at the 3.5 year check
Area of concern at 3.5 yrs Number of cases
Speech and language development 13 (76.5%)
Hearing 1 (5.9%)
Motor development 1 (5.9%)
Behaviour 8 (47.1%)
None 1 (5.9%)
Table 4 shows the areas of concerns which were documented in the 
child health surveillance check at 3.5 years of age in children with 
PDD (n = 17). In six children 2 areas of concern were documented. In 
four children no data concerning the check was available, in 2 cases 
because the child had moved into the area at a later point.
Table 5: Areas of concern raised in the initial referral letter
Area of concern at referral Number of children
Speech and language development 18 (85.7%)
Motor development 2 (9.5%)
Social interaction 10 (47.6%)
Unusual behaviour 9 (42.9%)
Aggressive behaviour 2 (9.5%)
Short attention span 4 (19.0%)
Table 5 shows the areas of concerns raised in the initial referral letter 
(n = 21). In some children there was more than one area of concern 
mentioned in the letter.BMC Pediatrics 2004, 4 http://www.biomedcentral.com/1471-2431/4/4
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All Children" [24]. The authors of this document are pro-
posing that no formal universal screening should be car-
ried out at 2 years (i.e. 18–24 months) and 3.5 years (i.e.
39–42 months). Instead they recommend a strategy
whereby the health visitor negotiates the nature of subse-
quent reviews at the age of four months with the parents
in the light of individual needs. However, at this age char-
acteristic features of PDD would not have developed. This
approach would rely mainly on the parents to recognise
autistic features or abnormal development and subse-
quently seek assistance from health care professionals.
Awareness training of play group and nursery staff as sug-
gested by the National Initiative for Autism: Screening
and Assessment (NIASA) may be an important tool to
overcome this problem [25].
The guidelines that have been proposed by NIASA con-
clude that primary screening for PDD by the use of tests
applied to the whole population at specific ages cannot be
recommended, based on previous reports (e.g. by Baird et
al. [26], who reported a low sensitivity of 38% for the
CHAT / Checklist for Autism in Toddlers). However, the
group of experts endorsed the recommendation that at
specific times in the pre-school years (8–12 months, 2–3
years and 3–5 years) there should be a focus on develop-
ment by a health professional with the parents or carer.
Early diagnosis of PDD is essential to facilitate early inter-
vention. Various forms of intervention have been shown
to be beneficial and improve overall outcome in non-ran-
domised studies [7,27,28]. More recently, two small ran-
domised controlled trials have demonstrated that early,
intensive therapy can improve the intellectual develop-
ment, language and visual-spatial skills of the affected
child as well as significantly increase parent satisfaction
[29,30]
The mainstays of therapy continue to be speech and lan-
guage therapy and behavioural therapy. One approach is
a TEACCH-based (Treatment and Education of Autistic
and related Communication handicapped CHildren)
home intervention programme, which has repeatedly
been shown to be effective. Ozonoff and Cathcart [31]
were able to demonstrate that children participating in
this programme improved significantly more than the
autistic children in the control group in the areas of fine
motor, gross motor and non-verbal conceptual skills.
Another promising approach is the NAS EarlyBird Pro-
gramme. There is already supporting evidence of its effi-
cacy, although long-term data requires further evaluation
[8]. The early intensive behavioural intervention method
(EIBI) is another behavioural approach which has been
reported to be an effective intervention which may
produce long-lasting and significant gains for young chil-
dren with autism [32,33]. However, the assessment and
evaluation of outcomes of interventions in complex disor-
ders such as PDD is difficult and further studies are
needed to evaluate the long-term impact of these
methods.
We are aware of the limitations of this study, most notably
that standardised assessment tools such as the widely used
ADI (Autism Diagnostic Interview) were not employed in
the initial diagnostic assessment. The diagnoses are based
on assessments mainly conducted by experienced Con-
sultants in Community Paediatrics, who are specifically
trained for this role, but are observer dependent. This
might have led to over-diagnosing or over-inclusion, espe-
cially at the "milder" end of the spectrum of PDD. The
second major shortfall of this study was that we did not
receive a response from all schools – which may have
affected our prevalence. However, our epidemiological
findings are consistent with observations reported by
other authors, who have employed different methods to
conduct their surveys.
Conclusions
The prevalences for PDD and the subcategories childhood
autism and Asperger's syndrome we established in this
study were similar to figures published recently, but much
higher than reported a few years ago. Our data suggests
that routine child health surveillance at 2 years and 3.5
years is a valuable contributing factor for the early detec-
tion of PDD, which ultimately facilitates early interven-
tion. Thus, if routine surveillance ceases, then an
appropriate alternative method of early detection should
be put in place.
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